Nitrosamine Impurities | USP

  Рет қаралды 5,215

US Pharmacopeia

US Pharmacopeia

Күн бұрын

This webinar aired live October 13, 2020. Speaker is Naiffer Romero, Senior Scientific Affairs Manager. Naiffer explains about the challenges related to nitrosamine impurities and informs on the overall control strategies for them. He then introduces to the new USP General Chapter 1469 Nitrosamine Impurities. Naiffer ends his talk by presenting the new USP RS for nitrosamines, to support testing procedures. Please send an email to emea@usp.org for any questions. www.usp.org/usp-switzerland

Пікірлер: 2
@merajkhan765
@merajkhan765 2 жыл бұрын
Very informative Presentation.
@tarunpratapnarayanmishra2642
@tarunpratapnarayanmishra2642 3 жыл бұрын
Very nice ppt Thanks
КАК ДУМАЕТЕ КТО ВЫЙГРАЕТ😂
00:29
МЯТНАЯ ФАНТА
Рет қаралды 11 МЛН
MISS CIRCLE STUDENTS BULLY ME!
00:12
Andreas Eskander
Рет қаралды 20 МЛН
Nitrosamines impurities by M. Filancia (EMA)
17:19
European Medicines Agency
Рет қаралды 2,8 М.
Introduction to Analytical Quality by Design (AQbD) principles
1:01:49
US Pharmacopeia
Рет қаралды 13 М.
Analytical Solutions for Nitrosamines in Response to USP
38:54
Shimadzu Scientific Instruments
Рет қаралды 518
How to Define Limit For Newly Identified Nitrosamine Impurity?
17:16
Pharma Growth Hub
Рет қаралды 8 М.
Panel Discussion on peptides characterization and Impurities
47:39
US Pharmacopeia
Рет қаралды 221
How to define limit for unknown, known and total impurities
26:07
Pharma Growth Hub
Рет қаралды 54 М.
what is a nitrosamine? How is it formed?
5:19
Paulo Eliandro
Рет қаралды 6 М.